Brind.

BTIG maintained a Buy rating on Accuray on August 21, 2025.

1 report, 1 independent Updated Aug 21

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Accuray

How it developed

Newest first. Tap a step to see who reported it.

Jun 7Accuray reported lower product revenue from businesses in Japan.Sub-event
Aug 21BTIG maintained a Buy rating on Accuray.1 source
- Insider Monkey

Keep exploring

The entities involved

Accuray
American radiation therapy company
- Accuray announced new collaborations and expanded work with UW School of Medicine, Samsung Medison, and Tata Consultancy Services.Sun 17:51

Coverage

Newest first; wire copies grouped

Aug 21Insider MonkeyAccuray (ARAY) Beats Q4 Revenue Estimates, BTIG Maintains Buy Rating Accuray Incorporated (NASDAQ:ARAY) ranks among the top robotics to buy according to analysts. After Accuray Incorporated (NASDAQ:A